Now Available!|Research-Grade ActCel T Cell Activation Reagent – Free Trials for New Product
T cells are an elite force within our immune system, and T cell therapy is demonstrating significant potential in tackling challenging diseases like cancer and autoimmune disorders, offering new treatment options for more patients. Within T cell therapy, T cell activation is an essential step with a direct impact on treatment efficacy. If the activation intensity is too low, T cell transduction efficiency may decrease, impairing its antitumor effect. Conversely, excessive activation can lead to T cell exhaustion, compromising their persistence and function. Therefore, selecting an appropriate T cell activation reagent is crucial.
Typically, the CAR-T process includes steps such as patient blood collection, T cell isolation, T cell activation, transduction, expansion, and reinfusion. Among these, T cell activation is a critical step that not only influences subsequent cell proliferation but also directly affects the efficacy and persistence of CAR-T cell therapy. One of the most widely used strategies for T cell activation is to use CD3/CD28 antibody-coupled microbeads or nanoparticles, providing the necessary first and second signals required for T cell activation and proliferation. Nanoparticle-based reagents, with their ultra-fine particle size, remain evenly dispersed in the culture medium without sedimentation, offering uniform contact and activation of T cells, and require no pre-washing, making them easy to use. These advantages make nano-based T cell activation reagents an attractive option for CAR-T therapy.
Figure 1. Classic CAR-T Process Flow (Sophia Stock et al., Int. J. Mol. Sci. 2019, 20, 6223)
The research-grade ActCel T Cell Activation Reagent (Cat.No.GW-6001-1000), produced using advanced nano-magnetic bead technology, is coupled with anti-human CD3 and CD28 antibodies on a nano matrix. This reagent enables gentle and efficient activation of T cells, maintaining high viability and proliferation, making it an optimal choice for ex vivo T cell activation.
Product Highlights
01 Safe and Efficient: Provides gentle stimulation for T cell activation and proliferation
02 User-Friendly:Ready-to-use, directly applicable
03 Cost-Effective: Stable performance at a competitive price
Product Information
Product Performance
Figure 2. T cell expansion
Interested in trying our new ActCel T Cell Activation Reagent?
Contact us today to request a free sample and experience the benefits firsthand for your research!
G&W Biotechnologie GmbH who is an international reagent supplier and technology service provider, focuses on the industry of cell and gene therapy (CGT), provides one-stop core reagents and technical services for CGT users with an overall solution dedicated to providing reliable life sciences products and services.
Call us:+4901622140620
Email:gwbiotechnologie@gmail.com
Web:www.gwbioth.com
Address: Pfarrer-Bergmann-Straße 59,55127 Mainz, Deutschland